Bronchiectasis: a global disease necessitating global solutions

René Laennec's description of bronchiectasis, almost 200 years ago, serves as a timely reminder that if one does not look for something, we shall never find it. The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) provides the most comprehensive analysis of bronchiectasis clinical care available to date. 1 Chalmers JD Polverino E Crichton ML et al. Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC). Lancet Respir Med. 2023; (published online April 24.)https://doi.org/10.1016/S2213-2600(23)00093-0 Summary Full Text Full Text PDF PubMed Scopus (4) Google Scholar With 16 963 individuals enrolled across 27 European countries and Israel, consistent quality-controlled methodology, including longitudinal follow up, it serves as a reminder of the substantial unmet need in bronchiectasis clinical care and research. This snapshot of real-world practice will guide recalibration of clinical practice guidelines, clarify the educational needs of patients and physicians, and provide fresh directions for research. Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)Bronchiectasis shows important geographical variation in causes, microbiology, severity, and outcomes across Europe. Full-Text PDF Open Access